Stephanie Clemens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephanie Clemens has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Olaf Rose
Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University, 5020 Salzburg, Austria
13 shared publications - Johanna Pachmayr
Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University, 5020 Salzburg, Austria
8 shared publications Johanna Pachmayr
Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University, Salzburg, Austria
4 shared publications- Bernhard Iglseder
Universitätsklinik für Geriatrie der PMU, Uniklinikum Salzburg, Christian-Doppler-Klinik, Salzburg/Österreich, Österreich
2 shared publications Christina Dückelmann
Affiliations Institute of Pharmacy, Pharmaceutical Biology & Clinical Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria, Landesapotheke Salzburg, Salzburg, Austria
2 shared publications- Clarissa Egel
Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University, 5020 Salzburg, Austria
2 shared publications
Latest Publications
- Open Access
Beyond the Dispensary: Pharmacists’ Perspectives on the Responsible Implementation of Emerging Clinical, Digital, and Ethically Sensitive Roles
Pharmacy practice is expanding into clinical, digital, and ethically sensitive areas, yet professional support may not translate into implementation. Building on previous studies in point-of-care testing (POCT), artificial intelligence (AI), and assisted suicide, this exploratory convergent mixed-methods study used a purpose-designed symposium workshop focused on responsible implementation. Participants completed an anonymous 15-item questionnaire and submitted anonymous online barrier entries during the workshop. Of 45 returned questionnaires, 42 met the predefined completeness criterion for inferential analyses; 186 barrier entries were analyzed using structured qualitative content analysis. POCT showed high perceived capability, relevance, support, and willingness, while barriers centered on resources and economic viability. AI was considered highly relevant, but perceived capability was lower and concerns focused on reliability, regulation, accountability, and uncritical use. Pharmacist involvement in assisted suicide was broadly supported, while perceived capability was lower and barriers spanned ethical, organizational, legal, communicative, and emotional domains. These field-specific patterns were heuristically summarized as endorsement-capacity, capability-governance, and support-preparedness gaps. The labels are descriptive, non-validated summaries rather than participant-level mismatches. The findings suggest that professional support alone is an insufficient indicator of implementation readiness, as each activity was characterized by a distinct combination of capability, organizational capacity, and governance or support needs.
Open AccessBeyond the Dispensary: Pharmacists’ Perspectives on the Responsible Implementation of Emerging Clinical, Digital, and Ethically Sensitive Roles
Pharmacy practice is expanding into clinical, digital, and ethically sensitive areas, yet professional support may not translate into implementation. Building on previous studies in point-of-care testing (POCT), artificial intelligence (AI), and assisted suicide, this exploratory convergent mixed-methods study used a purpose-designed symposium workshop focused on responsible implementation. Participants completed an anonymous 15-item questionnaire and submitted anonymous online barrier entries during the workshop. Of 45 returned questionnaires, 42 met the predefined completeness criterion for inferential analyses; 186 barrier entries were analyzed using structured qualitative content analysis. POCT showed high perceived capability, relevance, support, and willingness, while barriers centered on resources and economic viability. AI was considered highly relevant, but perceived capability was lower and concerns focused on reliability, regulation, accountability, and uncritical use. Pharmacist involvement in assisted suicide was broadly supported, while perceived capability was lower and barriers spanned ethical, organizational, legal, communicative, and emotional domains. These field-specific patterns were heuristically summarized as endorsement-capacity, capability-governance, and support-preparedness gaps. The labels are descriptive, non-validated summaries rather than participant-level mismatches. The findings suggest that professional support alone is an insufficient indicator of implementation readiness, as each activity was characterized by a distinct combination of capability, organizational capacity, and governance or support needs.
- Open Access
- 21 August 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2279-2288
Development of a hybrid artificial intelligence framework for pharmacotherapy optimization
Introduction: Pharmacotherapy optimization in multimorbid patients is increasingly complex due to polypharmacy, fragmented data, expanding electronic health records, and workforce constraints. Conventional clinical decision support systems remain largely rule-based and often fail to adequately incorporate patient-specific context. While artificial intelligence offers new opportunities, stand-alone models remain insufficiently reliable for high-risk pharmacotherapy decision support. Aim: To develop a relevance-driven, clinician-supervised hybrid AI framework for pharmacotherapy optimization. Method: Using a design science-informed approach, an interdisciplinary research group developed a conceptual framework for AI-supported pharmacotherapy optimization. Framework development was informed by prior feasibility work, published literature, clinical practice requirements, and iterative interdisciplinary discussions. Hybrid AI was defined as the combination of retrieval-augmented generation, deterministic safety rules, and large language model reasoning. Results: Seven design principles were identified, including decomposition of clinical activities, relevance-based prioritization, hybrid reasoning under clinician oversight, integration of patient goals, transparency of evidence sources, longitudinal optimization within a governed closed loop, and evaluation as a design requirement. These principles informed a conceptual architecture integrating structured clinical data, patient preferences, longitudinal patient information, and evidence retrieval within a clinician-governed decision-support framework. Conclusion: The proposed framework conceptualizes AI as a relevance-structuring, clinician-governed decision-support layer rather than an autonomous decision-maker. By combining hybrid reasoning, patient-specific context, and professional oversight, it provides a conceptual foundation for future development, implementation, and evaluation of AI-supported pharmacotherapy systems.
- 21 August 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2279-2288
Open AccessDevelopment of a hybrid artificial intelligence framework for pharmacotherapy optimization
Introduction: Pharmacotherapy optimization in multimorbid patients is increasingly complex due to polypharmacy, fragmented data, expanding electronic health records, and workforce constraints. Conventional clinical decision support systems remain largely rule-based and often fail to adequately incorporate patient-specific context. While artificial intelligence offers new opportunities, stand-alone models remain insufficiently reliable for high-risk pharmacotherapy decision support. Aim: To develop a relevance-driven, clinician-supervised hybrid AI framework for pharmacotherapy optimization. Method: Using a design science-informed approach, an interdisciplinary research group developed a conceptual framework for AI-supported pharmacotherapy optimization. Framework development was informed by prior feasibility work, published literature, clinical practice requirements, and iterative interdisciplinary discussions. Hybrid AI was defined as the combination of retrieval-augmented generation, deterministic safety rules, and large language model reasoning. Results: Seven design principles were identified, including decomposition of clinical activities, relevance-based prioritization, hybrid reasoning under clinician oversight, integration of patient goals, transparency of evidence sources, longitudinal optimization within a governed closed loop, and evaluation as a design requirement. These principles informed a conceptual architecture integrating structured clinical data, patient preferences, longitudinal patient information, and evidence retrieval within a clinician-governed decision-support framework. Conclusion: The proposed framework conceptualizes AI as a relevance-structuring, clinician-governed decision-support layer rather than an autonomous decision-maker. By combining hybrid reasoning, patient-specific context, and professional oversight, it provides a conceptual foundation for future development, implementation, and evaluation of AI-supported pharmacotherapy systems.
- Open Access
- 13 February 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (2) , 173-181
Role of pharmacy education and pharmacy practice in developing pharmacists as researchers in Austria
Clinical pharmacy and pharmacy practice research in Austria has evolved more slowly than in some other countries, but recent years have seen notable progress. Geographic disparities still limit access in certain regions, yet policymakers increasingly acknowledge the essential role of pharmacies, while remaining focused on cost containment. Curricula at universities vary, with most universities still focussing on pharmaceutical chemistry and traditional content and one university teaching pharmacotherapy and medication review to a higher extent. The switch to the bachelor’s and master’s degree system has increased research involvement, as all pharmacy students must complete two original research projects for their theses. These projects often interact with pharmacy practice. Various postgraduate pathways support continued involvement in research. Fostered by the theses, pharmacy education develops research competence across the entire cohort rather than limiting it to a small academic subset. However, maintaining research engagement after graduation remains difficult. Once pharmacists enter practice, particularly in community settings, limited institutional links, lack of protected time, and scarce funding opportunities tend to interrupt this trajectory. A few postgraduate programs provide structured pathways to continue academic or clinical research, yet participation is optional and dependent on individual motivation. Strengthening continuity between academic training and professional environments would help consolidate the existing research competencies and foster a more sustainable research culture within the profession. The recently introduced mandatory system of continuing professional education further supports this development by bringing academia and practitioners closer together and by promoting a culture of shared learning and ongoing inquiry. Although the number of clinical pharmacists remains relatively low, their presence on hospital wards is expanding and increasingly valued, while community pharmacies are also beginning to offer clinical pharmacy services. Strengthening Austria’s pharmacy profession requires closer alignment between educational reform, professional practice, and health policy. Policymakers should make more systematic use of pharmacists’ competencies as accessible first points of contact within primary care. Expanding their scope to include structured involvement in the pharmacotherapy of prevalent chronic diseases such as atherosclerosis, diabetes, and hypertension, as well as in screening and prevention programs, would not only improve population health but also bring translational research closer to everyday pharmacy practice. Evidence demonstrates that Austrian pharmacists are well prepared for expanded clinical responsibilities and show high professional motivation to assume such roles. These developments should be accompanied by targeted curricular reforms that strengthen clinical reasoning, interprofessional collaboration, and applied research competencies. International collaboration and participation in European research and education networks can further enhance Austria’s research capacity and harmonize national progress with global best practices. By bridging policy, education, and professional development, pharmacists can evolve from their current multifaceted roles into active contributors to patient-centred research and evidence-based healthcare, while remaining closely connected to continuous education and research.
- 13 February 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (2) , 173-181
Open AccessRole of pharmacy education and pharmacy practice in developing pharmacists as researchers in Austria
Clinical pharmacy and pharmacy practice research in Austria has evolved more slowly than in some other countries, but recent years have seen notable progress. Geographic disparities still limit access in certain regions, yet policymakers increasingly acknowledge the essential role of pharmacies, while remaining focused on cost containment. Curricula at universities vary, with most universities still focussing on pharmaceutical chemistry and traditional content and one university teaching pharmacotherapy and medication review to a higher extent. The switch to the bachelor’s and master’s degree system has increased research involvement, as all pharmacy students must complete two original research projects for their theses. These projects often interact with pharmacy practice. Various postgraduate pathways support continued involvement in research. Fostered by the theses, pharmacy education develops research competence across the entire cohort rather than limiting it to a small academic subset. However, maintaining research engagement after graduation remains difficult. Once pharmacists enter practice, particularly in community settings, limited institutional links, lack of protected time, and scarce funding opportunities tend to interrupt this trajectory. A few postgraduate programs provide structured pathways to continue academic or clinical research, yet participation is optional and dependent on individual motivation. Strengthening continuity between academic training and professional environments would help consolidate the existing research competencies and foster a more sustainable research culture within the profession. The recently introduced mandatory system of continuing professional education further supports this development by bringing academia and practitioners closer together and by promoting a culture of shared learning and ongoing inquiry. Although the number of clinical pharmacists remains relatively low, their presence on hospital wards is expanding and increasingly valued, while community pharmacies are also beginning to offer clinical pharmacy services. Strengthening Austria’s pharmacy profession requires closer alignment between educational reform, professional practice, and health policy. Policymakers should make more systematic use of pharmacists’ competencies as accessible first points of contact within primary care. Expanding their scope to include structured involvement in the pharmacotherapy of prevalent chronic diseases such as atherosclerosis, diabetes, and hypertension, as well as in screening and prevention programs, would not only improve population health but also bring translational research closer to everyday pharmacy practice. Evidence demonstrates that Austrian pharmacists are well prepared for expanded clinical responsibilities and show high professional motivation to assume such roles. These developments should be accompanied by targeted curricular reforms that strengthen clinical reasoning, interprofessional collaboration, and applied research competencies. International collaboration and participation in European research and education networks can further enhance Austria’s research capacity and harmonize national progress with global best practices. By bridging policy, education, and professional development, pharmacists can evolve from their current multifaceted roles into active contributors to patient-centred research and evidence-based healthcare, while remaining closely connected to continuous education and research.
- Open Access
Patient and Physician Perspectives on Pharmacotherapy in Parkinson’s Disease Psychosis: A Mixed-Methods Exploratory Study
Psychosis is a frequent and disabling non-motor complication of Parkinson’s disease (PD). Clozapine and quetiapine are widely used in the treatment of Parkinson’s disease psychosis (PDP). We conducted an exploratory study to compare patient experiences with physician prescribing practices. Patients with PDP hospitalized at a university center completed semi-structured interviews on perceived efficacy, adverse effects, and daily functioning. Neurologists and geriatricians attending training sessions completed a structured questionnaire on prescribing patterns, attitudes toward clozapine, and perceived treatment burden. Data were analyzed thematically and triangulated across cohorts. Eleven patients (mean age 81 years; nine treated with quetiapine, two with clozapine) were included. Most quetiapine-treated patients reported persistent hallucinations, sedation, dizziness, and reduced autonomy. Fourteen physicians completed the survey and most preferred quetiapine, citing monitoring logistics and agranulocytosis risk as barriers to clozapine. Overall, patient priorities centered on symptom control and independence, whereas physician decisions emphasized feasibility and safety. Facilitating clozapine monitoring and incorporating patient-reported outcomes into routine care may improve patient-centered PDP management.
Open AccessPatient and Physician Perspectives on Pharmacotherapy in Parkinson’s Disease Psychosis: A Mixed-Methods Exploratory Study
Psychosis is a frequent and disabling non-motor complication of Parkinson’s disease (PD). Clozapine and quetiapine are widely used in the treatment of Parkinson’s disease psychosis (PDP). We conducted an exploratory study to compare patient experiences with physician prescribing practices. Patients with PDP hospitalized at a university center completed semi-structured interviews on perceived efficacy, adverse effects, and daily functioning. Neurologists and geriatricians attending training sessions completed a structured questionnaire on prescribing patterns, attitudes toward clozapine, and perceived treatment burden. Data were analyzed thematically and triangulated across cohorts. Eleven patients (mean age 81 years; nine treated with quetiapine, two with clozapine) were included. Most quetiapine-treated patients reported persistent hallucinations, sedation, dizziness, and reduced autonomy. Fourteen physicians completed the survey and most preferred quetiapine, citing monitoring logistics and agranulocytosis risk as barriers to clozapine. Overall, patient priorities centered on symptom control and independence, whereas physician decisions emphasized feasibility and safety. Facilitating clozapine monitoring and incorporating patient-reported outcomes into routine care may improve patient-centered PDP management.
- Open Access
- 7 January 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Final destination – pharmacists’ perspectives on assisted suicide (the PAS-study): a cross-sectional convergent parallel mixed-methods study
Assisted suicide is discussed in many countries to permit terminal-ill patients to die in dignity. Pharmacists often have the last interaction with the patients. This study aimed to explore Austrian pharmacists’ perspectives on assisted suicide and to identify challenges and strategies for improving this service. The study was a cross-sectional convergent parallel mixed-methods study. The quantitative component involved digital surveys distributed by the Austrian Board of Pharmacists. The qualitative phase included semi-structured interviews with pharmacists who had experience dispensing lethal drugs. Quantitative data were analysed using SPSS and qualitative data through Mayring’s content analysis with MAXQDA. Findings were integrated through mixed-methods matrices for comparison and strategy development. The study was registered in the German Clinical Trials Register (DRKS00034077). A total of 324 pharmacists participated (193 enrolled and 131 non-enrolled) yielding a 5.11% total response rate. Over half of the enrolled pharmacists (52.8%) had dispensed the lethal drug, viewing their involvement as a responsibility (55.6%) and feeling mentally capable (44%). Nearly half of non-enrolled pharmacists (42%) opposed participation, citing safety concerns and fear of mental burden. In-depth interviews (n = 5) highlighted the emotional strain on patients and pharmacists. Older pharmacists felt more prepared than younger ones (ρ = −0.295, p = 0.001). Enrolled pharmacists viewed training as helpful, while non-enrolled saw it as a barrier, emphasising the need for better communication and support. The study identified key issues and areas for improving care and pharmacist enrolment. Frameworks can assist pharmacists supporting patients facing their last destination, while also providing room for their own reflection. Trial registration: German Clinical Trials Register identifier: DRKS00034077.
- 7 January 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Open AccessFinal destination – pharmacists’ perspectives on assisted suicide (the PAS-study): a cross-sectional convergent parallel mixed-methods study
Assisted suicide is discussed in many countries to permit terminal-ill patients to die in dignity. Pharmacists often have the last interaction with the patients. This study aimed to explore Austrian pharmacists’ perspectives on assisted suicide and to identify challenges and strategies for improving this service. The study was a cross-sectional convergent parallel mixed-methods study. The quantitative component involved digital surveys distributed by the Austrian Board of Pharmacists. The qualitative phase included semi-structured interviews with pharmacists who had experience dispensing lethal drugs. Quantitative data were analysed using SPSS and qualitative data through Mayring’s content analysis with MAXQDA. Findings were integrated through mixed-methods matrices for comparison and strategy development. The study was registered in the German Clinical Trials Register (DRKS00034077). A total of 324 pharmacists participated (193 enrolled and 131 non-enrolled) yielding a 5.11% total response rate. Over half of the enrolled pharmacists (52.8%) had dispensed the lethal drug, viewing their involvement as a responsibility (55.6%) and feeling mentally capable (44%). Nearly half of non-enrolled pharmacists (42%) opposed participation, citing safety concerns and fear of mental burden. In-depth interviews (n = 5) highlighted the emotional strain on patients and pharmacists. Older pharmacists felt more prepared than younger ones (ρ = −0.295, p = 0.001). Enrolled pharmacists viewed training as helpful, while non-enrolled saw it as a barrier, emphasising the need for better communication and support. The study identified key issues and areas for improving care and pharmacist enrolment. Frameworks can assist pharmacists supporting patients facing their last destination, while also providing room for their own reflection. Trial registration: German Clinical Trials Register identifier: DRKS00034077.
- Open Access
Community Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications
Increasing healthcare demands and physician shortages have prompted many countries to expand clinical responsibilities of pharmacists. Although Canada, the UK, and the US have implemented pharmacist prescribing, other nations lag behind. This review compares international roles, identifies inferred competencies, and explores implications for role expansion. A systematic search of MEDLINE, CINAHL, and the Cochrane Library was conducted using the PICO framework; studies were appraised with Critical Appraisal Skills Programme (CASP) checklists, and interrater reliability assessed via Cohen’s Kappa. Data from 23 studies were thematically synthesized following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Four themes emerged: (1) expanding clinical and public health roles and pharmacists’ self-perceived readiness; (2) regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions; (3) inferred competencies, including micro-skills (patient assessment, guideline application) and macro-capabilities (clinical judgment, accountability, reflective practice); and (4) contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges. Implementation implications were synthesized and included training, funding, acceptance, and integration. Evidence indicates pharmacist prescribing is safe and patient-centered when supported by regulation, structured training, and systemic integration. Insights from established models can guide incremental implementation, optimizing medication management, enhancing healthcare access, and promoting equitable care.
Open AccessCommunity Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications
Increasing healthcare demands and physician shortages have prompted many countries to expand clinical responsibilities of pharmacists. Although Canada, the UK, and the US have implemented pharmacist prescribing, other nations lag behind. This review compares international roles, identifies inferred competencies, and explores implications for role expansion. A systematic search of MEDLINE, CINAHL, and the Cochrane Library was conducted using the PICO framework; studies were appraised with Critical Appraisal Skills Programme (CASP) checklists, and interrater reliability assessed via Cohen’s Kappa. Data from 23 studies were thematically synthesized following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Four themes emerged: (1) expanding clinical and public health roles and pharmacists’ self-perceived readiness; (2) regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions; (3) inferred competencies, including micro-skills (patient assessment, guideline application) and macro-capabilities (clinical judgment, accountability, reflective practice); and (4) contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges. Implementation implications were synthesized and included training, funding, acceptance, and integration. Evidence indicates pharmacist prescribing is safe and patient-centered when supported by regulation, structured training, and systemic integration. Insights from established models can guide incremental implementation, optimizing medication management, enhancing healthcare access, and promoting equitable care.
- Open Access
- 26 September 2025
- Published by MDPI AG in Preprints.org
Community Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications
Rising healthcare demands and physician shortages have led many countries to expand pharmacists’ clinical roles, including prescribing. While Canada, the UK, and the US have implemented pharmacist prescribing, other nations lag behind. This review compares international roles, identifies inferred competencies, and explores implications for role expansion. A systematic search of MEDLINE, CINAHL, and the Cochrane Library was conducted using the PICO framework; studies were appraised with CASP checklists, and interrater reliability assessed via Cohen’s Kappa. Data from 23 studies were thematically synthesized following PRISMA 2020 guidelines. Four key themes emerged: (1) expanding clinical and public health roles and pharmacists’ self-perceived readiness; (2) regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions; (3) inferred competencies, including micro-skills (patient assessment, guideline application) and macro-capabilities (clinical judgment, accountability, reflective practice); and (4) contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges. Implications for implementation were synthesized among these key themes and included: training, funding, acceptance, and integration. Evidence indicates pharmacist prescribing is safe and patient-centered when supported by regulation, structured training, and systemic integration. Insights from established models can guide incremental implementation, optimizing medication management, enhancing healthcare access, and promoting equitable care.
- 26 September 2025
- Published by MDPI AG in Preprints.org
Open AccessCommunity Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications
Rising healthcare demands and physician shortages have led many countries to expand pharmacists’ clinical roles, including prescribing. While Canada, the UK, and the US have implemented pharmacist prescribing, other nations lag behind. This review compares international roles, identifies inferred competencies, and explores implications for role expansion. A systematic search of MEDLINE, CINAHL, and the Cochrane Library was conducted using the PICO framework; studies were appraised with CASP checklists, and interrater reliability assessed via Cohen’s Kappa. Data from 23 studies were thematically synthesized following PRISMA 2020 guidelines. Four key themes emerged: (1) expanding clinical and public health roles and pharmacists’ self-perceived readiness; (2) regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions; (3) inferred competencies, including micro-skills (patient assessment, guideline application) and macro-capabilities (clinical judgment, accountability, reflective practice); and (4) contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges. Implications for implementation were synthesized among these key themes and included: training, funding, acceptance, and integration. Evidence indicates pharmacist prescribing is safe and patient-centered when supported by regulation, structured training, and systemic integration. Insights from established models can guide incremental implementation, optimizing medication management, enhancing healthcare access, and promoting equitable care.
- Open Access
- 23 September 2025
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 18 (1)
Drug shortages: clinical implications and burdens – a trinational multiple-methods study including key stakeholders
As the prevalence of drug shortages has markedly escalated in recent years, this study seeks to investigate the associated clinical implications and burdens in Austria, Germany and Kosovo where healthcare systems differ significantly. The research was conducted as a trinational, multiple-methods study utilising questionnaires and in-depth interviews for different stakeholders, including patients, physicians, pharmacists and manufacturers. Descriptive statistics were applied to summarise and analyse the quantitative dataset, providing key insights into central tendencies and overall data distribution, while qualitative data were analysed using the summarising approach based on Mayring’s qualitative content analysis. Manufacturers expressed concerns regarding the intense pressure on pricing amid global inflation. Proposed mitigation strategies were anticipated to incur higher costs, with increased stockpiling in one major country adversely affecting others. Pharmacists across all three nations reported significant disruptions to their clinical practice, with up to fifty per cent of patient encounters being affected by drug shortages, requiring considerable amounts of time to resolve. They expressed feelings of frustration and anger, citing bureaucratic obstacles and excessive regulation as impediments to effective problem-solving. Physicians reported similar challenges in their practice, often resorting to self-initiated solutions and advocating for improved information regarding drug availability. While most patients have been exposed to drug shortages, the majority of these issues were resolved with moderate interruptions to their therapy. The root causes of these problems were primarily attributed to political factors. The results show that drug shortages have significantly disrupted clinical practice across all three countries, with pharmacists and physicians reporting major impacts on patient care and increased time spent resolving issues. Economic pressures, political factors and regulatory obstacles were identified as key causes exacerbating the crisis and highlighting the need for coordinated mitigation strategies.
- 23 September 2025
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 18 (1)
Open AccessDrug shortages: clinical implications and burdens – a trinational multiple-methods study including key stakeholders
As the prevalence of drug shortages has markedly escalated in recent years, this study seeks to investigate the associated clinical implications and burdens in Austria, Germany and Kosovo where healthcare systems differ significantly. The research was conducted as a trinational, multiple-methods study utilising questionnaires and in-depth interviews for different stakeholders, including patients, physicians, pharmacists and manufacturers. Descriptive statistics were applied to summarise and analyse the quantitative dataset, providing key insights into central tendencies and overall data distribution, while qualitative data were analysed using the summarising approach based on Mayring’s qualitative content analysis. Manufacturers expressed concerns regarding the intense pressure on pricing amid global inflation. Proposed mitigation strategies were anticipated to incur higher costs, with increased stockpiling in one major country adversely affecting others. Pharmacists across all three nations reported significant disruptions to their clinical practice, with up to fifty per cent of patient encounters being affected by drug shortages, requiring considerable amounts of time to resolve. They expressed feelings of frustration and anger, citing bureaucratic obstacles and excessive regulation as impediments to effective problem-solving. Physicians reported similar challenges in their practice, often resorting to self-initiated solutions and advocating for improved information regarding drug availability. While most patients have been exposed to drug shortages, the majority of these issues were resolved with moderate interruptions to their therapy. The root causes of these problems were primarily attributed to political factors. The results show that drug shortages have significantly disrupted clinical practice across all three countries, with pharmacists and physicians reporting major impacts on patient care and increased time spent resolving issues. Economic pressures, political factors and regulatory obstacles were identified as key causes exacerbating the crisis and highlighting the need for coordinated mitigation strategies.
- Open Access
Pharmacist-Led Prescribing in Austria: A Mixed-Methods Study on Clinical Readiness and Legal Frameworks
In Austria, community pharmacists may dispense prescription-only drugs in exceptional emergency cases. Hospital pharmacists are permitted to adapt or discontinue therapy with prior physician approval. This mixed-methods study explores how Austrian pharmacists interpret and apply these frameworks, their readiness for expanded roles, and the systemic conditions required to support broader clinical engagement. A cross-sectional design was used with two online surveys targeting community and hospital pharmacists. Additionally, 15 semi-structured interviews were conducted (ten community, five hospital pharmacists). Quantitative data were analyzed descriptively; qualitative data were examined using Mayring’s content analysis. Data integration followed a triangulation design via mixed-methods matrices. A total of 238 community and 53 hospital pharmacists responded. Findings show that community pharmacists frequently apply clinical judgment in urgent situations and navigate regulatory grey zones. Over 88% support expanded roles, particularly in continuing contraceptives, managing chronic diseases, and treating infections using point-of-care testing. Hospital pharmacists report limited implementation of their framework, hindered by institutional inertia, staffing shortages, and poor access to patient data. Confidence in clinical pharmacotherapy decisions was limited. Targeted training and policy support are essential.
Open AccessPharmacist-Led Prescribing in Austria: A Mixed-Methods Study on Clinical Readiness and Legal Frameworks
In Austria, community pharmacists may dispense prescription-only drugs in exceptional emergency cases. Hospital pharmacists are permitted to adapt or discontinue therapy with prior physician approval. This mixed-methods study explores how Austrian pharmacists interpret and apply these frameworks, their readiness for expanded roles, and the systemic conditions required to support broader clinical engagement. A cross-sectional design was used with two online surveys targeting community and hospital pharmacists. Additionally, 15 semi-structured interviews were conducted (ten community, five hospital pharmacists). Quantitative data were analyzed descriptively; qualitative data were examined using Mayring’s content analysis. Data integration followed a triangulation design via mixed-methods matrices. A total of 238 community and 53 hospital pharmacists responded. Findings show that community pharmacists frequently apply clinical judgment in urgent situations and navigate regulatory grey zones. Over 88% support expanded roles, particularly in continuing contraceptives, managing chronic diseases, and treating infections using point-of-care testing. Hospital pharmacists report limited implementation of their framework, hindered by institutional inertia, staffing shortages, and poor access to patient data. Confidence in clinical pharmacotherapy decisions was limited. Targeted training and policy support are essential.
- Open Access
- 2 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0326088
Development and validation of a risk prediction tool for drug-related problems in pre-operative elective surgical patients (mediPORT): A case-control study
Background: Drug-related problems (DRP) in pre-operative care can harm patient outcomes. This study aimed to develop and validate a pre-operative risk prediction tool (mediPORT) to calculate the probability of DRP in admitted patients. Methods: Elective surgery patients aged ≥ 18 years admitted to the pre-anaesthesia clinic and participating in a medication review by pharmacists were included in this case-control study. Routinely reported patient variables were included in a backward stepwise logistic regression to determine the most relevant predictors (minimum Akaike Information Criterion) of DRP. Performances using the area under the receiver operating characteristic curve (AUC) were assessed to test the model. Internal validation was performed using a 10-fold cross-validation procedure. Results: The target population consisted of 11,176 participants, of whom 284 cases with ≥ 1 DRP and 980 controls without DRP were drawn. Most relevant predictors for DRP were age, number of drugs at admission, body mass index, sex and renal function. These factors were included in the final five variable model. A correlation between renal function and occurrence of DRP was found. Age and number of drugs frequently appeared in all models of the backwards elimination and represented an alternative two variable model. The AUC for predicting DRP were 0.823 (CI 95% 0.766–0.879) for the five-variable model and 0.872 (CI 95% 0.835–0.909) for the two-variable model. In the validation model, sensitivity was 77.6% and specificity was 76.5% for the five-variable model and 81.3%, 75% for the two-variable model, respectively. Conclusions: Resulting equations can be used by hospital admission to identify patients at high risk, for whom a precise assessment of medication is critical.
- 2 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0326088
Open AccessDevelopment and validation of a risk prediction tool for drug-related problems in pre-operative elective surgical patients (mediPORT): A case-control study
Background: Drug-related problems (DRP) in pre-operative care can harm patient outcomes. This study aimed to develop and validate a pre-operative risk prediction tool (mediPORT) to calculate the probability of DRP in admitted patients. Methods: Elective surgery patients aged ≥ 18 years admitted to the pre-anaesthesia clinic and participating in a medication review by pharmacists were included in this case-control study. Routinely reported patient variables were included in a backward stepwise logistic regression to determine the most relevant predictors (minimum Akaike Information Criterion) of DRP. Performances using the area under the receiver operating characteristic curve (AUC) were assessed to test the model. Internal validation was performed using a 10-fold cross-validation procedure. Results: The target population consisted of 11,176 participants, of whom 284 cases with ≥ 1 DRP and 980 controls without DRP were drawn. Most relevant predictors for DRP were age, number of drugs at admission, body mass index, sex and renal function. These factors were included in the final five variable model. A correlation between renal function and occurrence of DRP was found. Age and number of drugs frequently appeared in all models of the backwards elimination and represented an alternative two variable model. The AUC for predicting DRP were 0.823 (CI 95% 0.766–0.879) for the five-variable model and 0.872 (CI 95% 0.835–0.909) for the two-variable model. In the validation model, sensitivity was 77.6% and specificity was 76.5% for the five-variable model and 81.3%, 75% for the two-variable model, respectively. Conclusions: Resulting equations can be used by hospital admission to identify patients at high risk, for whom a precise assessment of medication is critical.